200 related articles for article (PubMed ID: 31941718)
21. The Composition of Reconstituted High-Density Lipoproteins (rHDL) Dictates the Degree of rHDL Cargo- and Size-Remodeling via Direct Interactions with Endogenous Lipoproteins.
Pedersbæk D; Kræmer MK; Kempen PJ; Ashley J; Braesch-Andersen S; Andresen TL; Simonsen JB
Bioconjug Chem; 2019 Oct; 30(10):2634-2646. PubMed ID: 31487985
[TBL] [Abstract][Full Text] [Related]
22. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size.
Maiorano JN; Jandacek RJ; Horace EM; Davidson WS
Biochemistry; 2004 Sep; 43(37):11717-26. PubMed ID: 15362856
[TBL] [Abstract][Full Text] [Related]
23. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
Mahmoudian M; Salatin S; Khosroushahi AY
Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
[TBL] [Abstract][Full Text] [Related]
24. In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.
Zhao Y; Black AS; Bonnet DJ; Maryanoff BE; Curtiss LK; Leman LJ; Ghadiri MR
J Lipid Res; 2014 Oct; 55(10):2053-63. PubMed ID: 24975585
[TBL] [Abstract][Full Text] [Related]
25. Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles.
Lin Q; Chen J; Jin H; Ng KK; Yang M; Cao W; Ding L; Zhang Z; Zheng G
Nanomedicine (Lond); 2012 Dec; 7(12):1813-25. PubMed ID: 22830501
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
Zhao Y; Jiang C; He J; Guo Q; Lu J; Yang Y; Zhang W; Liu J
Bioconjug Chem; 2017 Feb; 28(2):438-448. PubMed ID: 28004910
[TBL] [Abstract][Full Text] [Related]
27. Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins.
Demoor L; Boutillon C; Fievet C; Vanloo B; Baert J; Rosseneu M; Fruchart JC; Tartar A
Eur J Biochem; 1996 Jul; 239(1):74-84. PubMed ID: 8706721
[TBL] [Abstract][Full Text] [Related]
28. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly.
Palgunachari MN; Mishra VK; Lund-Katz S; Phillips MC; Adeyeye SO; Alluri S; Anantharamaiah GM; Segrest JP
Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):328-38. PubMed ID: 8620350
[TBL] [Abstract][Full Text] [Related]
29. Potential clinical utility of high-density lipoprotein-mimetic peptides.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169
[TBL] [Abstract][Full Text] [Related]
30. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
[TBL] [Abstract][Full Text] [Related]
31. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.
Mooberry LK; Nair M; Paranjape S; McConathy WJ; Lacko AG
J Drug Target; 2010 Jan; 18(1):53-8. PubMed ID: 19637935
[TBL] [Abstract][Full Text] [Related]
32. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
[TBL] [Abstract][Full Text] [Related]
33. A short amphipathic alpha helix in scavenger receptor BI facilitates bidirectional HDL-cholesterol transport.
May SC; Sahoo D
J Biol Chem; 2022 Sep; 298(9):102333. PubMed ID: 35926711
[TBL] [Abstract][Full Text] [Related]
34. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
36. Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles.
Zheng Y; Liu Y; Jin H; Pan S; Qian Y; Huang C; Zeng Y; Luo Q; Zeng M; Zhang Z
Theranostics; 2013; 3(7):477-86. PubMed ID: 23843895
[TBL] [Abstract][Full Text] [Related]
37. Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.
Sigalov AB
Contrast Media Mol Imaging; 2014; 9(5):372-82. PubMed ID: 24729189
[TBL] [Abstract][Full Text] [Related]
38. Targeted delivery of garcinia glycosides by reconstituted high-density lipoprotein nano-complexes.
Liu C; Zhou Z; Chen Y; Liu J; Wang Y; Liu H
J Microencapsul; 2018 Mar; 35(2):115-120. PubMed ID: 29195484
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein-inspired penetrating nanoparticles for deep tumor-targeted shuttling of indocyanine green and enhanced photo-theranostics.
Sheng Y; Wang Z; Ngandeu Neubi GM; Cheng H; Zhang C; Zhang H; Wang R; Zhou J; Ding Y
Biomater Sci; 2019 Aug; 7(8):3425-3437. PubMed ID: 31268061
[TBL] [Abstract][Full Text] [Related]
40. Preparation and Characterization of Stable α-Synuclein Lipoprotein Particles.
Eichmann C; Campioni S; Kowal J; Maslennikov I; Gerez J; Liu X; Verasdonck J; Nespovitaya N; Choe S; Meier BH; Picotti P; Rizo J; Stahlberg H; Riek R
J Biol Chem; 2016 Apr; 291(16):8516-27. PubMed ID: 26846854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
